Targeting mutant estrogen receptors.
Where this comes from
- Record sourced from PubMed, PMID 30648967.
- Also identified by DOI 10.7554/eLife.44181 and PMC identifier 6335051.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
A drug used in hormone replacement therapy can target estrogen receptors that have become resistant to breast cancer treatments.
Medical subject headings
- Mutant Proteins
- Receptors, Estrogen